| Serum potassium, end-stage renal disease and mortality in chronic kidney disease GN Nakhoul, H Huang, S Arrigain, SE Jolly, JD Schold, JV Nally Jr, ... American journal of nephrology 41 (6), 456-463, 2015 | 180 | 2015 |
| Geographic trends, patient characteristics, and outcomes of infective endocarditis associated with drug abuse in the United States from 2002 to 2016 AN Kadri, B Wilner, AV Hernandez, G Nakhoul, J Chahine, B Griffin, ... Journal of the American Heart Association 8 (19), e012969, 2019 | 138 | 2019 |
| Therapeutic advances in diabetic nephropathy H Sawaf, G Thomas, JJ Taliercio, G Nakhoul, TJ Vachharajani, A Mehdi Journal of Clinical Medicine 11 (2), 378, 2022 | 73 | 2022 |
| Anemia of chronic kidney disease: Treat it, but not too aggressively G Nakhoul, JF Simon Cleve Clin J Med 83 (8), 613-624, 2016 | 61 | 2016 |
| Management of adults with acute streptococcal pharyngitis: minimal value for backup strep testing and overuse of antibiotics GN Nakhoul, J Hickner Journal of general internal medicine 28, 830-834, 2013 | 60 | 2013 |
| Off-clamp vs on-clamp robotic partial nephrectomy: perioperative, functional and oncological outcomes from a propensity-score matching between two high-volume centers R Bertolo, G Simone, J Garisto, G Nakhoul, S Armanyous, J Agudelo, ... European Journal of Surgical Oncology 45 (7), 1232-1237, 2019 | 45 | 2019 |
| Mortality outcomes of patients with chronic kidney disease and chronic obstructive pulmonary disease SD Navaneethan, JD Schold, H Huang, G Nakhoul, SE Jolly, S Arrigain, ... American journal of nephrology 43 (1), 39-46, 2016 | 42 | 2016 |
| Pragmatic randomized, controlled trial of patient navigators and enhanced personal health records in CKD SD Navaneethan, SE Jolly, JD Schold, S Arrigain, G Nakhoul, V Konig, ... Clinical Journal of the American Society of Nephrology 12 (9), 1418-1427, 2017 | 40 | 2017 |
| Impact of uric acid levels on kidney disease progression H Rincon-Choles, SE Jolly, S Arrigain, V Konig, JD Schold, G Nakhoul, ... American Journal of Nephrology 46 (4), 315-322, 2017 | 37 | 2017 |
| Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis GN Nakhoul, JD Schold, S Arrigain, SC Harb, S Jolly, BL Wilkoff, ... Clinical Journal of the American Society of Nephrology 10 (7), 1119-1127, 2015 | 37 | 2015 |
| Intra-arterial versus intravenous contrast and renal injury in chronic kidney disease: a propensity-matched analysis P Chaudhury, S Armanyous, SC Harb, L Ferreira Provenzano, T Ashour, ... Nephron 141 (1), 31-40, 2019 | 30 | 2019 |
| Immune check point inhibitor–associated glomerulonephritis T Ashour, G Nakhoul, P Patil, P Funchain, L Herlitz Kidney international reports 4 (2), 355-359, 2019 | 24 | 2019 |
| Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression L Cholin, T Ashour, A Mehdi, JJ Taliercio, R Daou, S Arrigain, JD Schold, ... BMC nephrology 22, 1-8, 2021 | 20 | 2021 |
| Residents’ perception of the nephrology specialty GN Nakhoul, A Mehdi, JJ Taliercio, A Brateanu, A Diwakar, R Daou, ... Kidney International Reports 5 (1), 94-99, 2020 | 19 | 2020 |
| Barriers to accessing essential medicines for kidney disease in low-and lower middle–income countries| A Francis, MIA Hafidz, UE Ekrikpo, T Chen, E Wijewickrama, EK Tannor, ... Kidney international 102 (5), 969-973, 2022 | 17 | 2022 |
| Contrast media in patients with kidney disease: An update JJ Taliercio Cleveland Clinic journal of medicine 87 (11), 683, 2020 | 16 | 2020 |
| Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial N Staplin, R Haynes, PK Judge, C Wanner, JB Green, J Emberson, ... The Lancet Diabetes & Endocrinology 12 (1), 39-50, 2024 | 15 | 2024 |
| Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial PK Judge, N Staplin, KJ Mayne, C Wanner, JB Green, SJ Hauske, ... The Lancet Diabetes & Endocrinology 12 (1), 51-60, 2024 | 12 | 2024 |
| Aspirin for primary and secondary prevention of mortality, cardiovascular disease, and kidney failure in the chronic renal insufficiency cohort (CRIC) study JJ Taliercio, G Nakhoul, A Mehdi, W Yang, D Sha, JD Schold, S Kasner, ... Kidney Medicine 4 (11), 100547, 2022 | 11 | 2022 |
| Phosphorus binders: The new and the old, and how to choose A Sekar, T Kaur, JV Nally, H Rincon-Choles, S Jolly, GN Nakhoul Cleve Clin J Med 85 (8), 629-38, 2018 | 11 | 2018 |
